Estimating disparities in breast cancer screening programs towards mortality, case fatality, and DALYs across BRICS-plus

Table 2 Mixed-effect multilevel regression to assess the relationship between age-standardized breast cancer mortality, disability, case fatality, and breast cancer screening (BCS) programs, by country-income levels (high-, middle-, low-income) across BRICS-plus

	HICs		MICs		LICs
	Estimate	95% CI	Estimate	95% CI	Estimate	95% CI
Mortality
No country/pilot screening program^a	Reference		Reference		Reference
National-wise screening program	− 13.10	− 16.21 to − 12.34	− 9.56	− 11.01 to − 8.99	2.11	− 2.03 to 9.65
Regional-wise screening program	− 10.41	− 15.32 to − 8.01	− 8.22	− 10.33 to − 7.56	− 1.43	− 2.44 to 8.54
DALYs
No country/pilot screening program^a	Reference		Reference		Reference
National-wise screening program	− 196.82	− 202.65 to − 191.10	− 165.4	− 169.02 to − 163.76	137.77	− 87.41 to 159.20
Regional-wise screening program	− 123.41	− 126.61 to 121.23	− 112.87	− 114.45 to 86.77	108.44	− 99.23 to 111.46
Case fatality (CF)
No country/pilot screening program^a	Reference
National-wise screening program	− 0.72	− 0.87 to − 0.63	− 0.61	− 0.69 to − 0.60	− 0.41	− 0.51 to 2.76
Regional-wise screening program	− 0.56	− 0.73 to − 0.41	− 0.43	− 0.44 to − 0.41	− 0.47	− 0.66 to 3.41

Models are equally adjusted as previous tables. 95 CI, 95% confidence interval; DALYs, disability-adjusted life years; HICs, high-income countries; MICs, middle-income countries; LICs, low-income countries
^aNo country program or existence of an opportunistic or pilot screening program

ISSN: 1741-7015